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Abstract
Thimerosal is one of the most widely used preservatives and has been reported to cause chemically mediated side effects. However, the
mechanism of the side effects is not clearly understood yet. In the present study, we showed that HeLa S cells treated by thimerosal generated
reactive oxygen species (ROS). Thimerosal-generated ROS stimulated the tyrosine phosphorylation of focal adhesion kinase (FAK) and also
induced cytoskeletal changes. Pretreatment with intracellular calcium chelator, BAPTA did not block the thimerosal-mediated FAK tyrosine
phosphorylation. On the other hand, either FAK inhibitor, tyrphostin or ROS scavenger, N-acetyl-L-cysteine (NAC) suppressed the tyrosine
phosphorylation and cytoskeletal changes. These results suggest that thimerosal seems to induce FAK tyrosine phosphorylation and
cytoskeletal changes by ROS generation but not by intracellular calcium mobilization. We think the present finding can be an important clue
to understanding the mechanism of thimerosal-mediated side effects, such as contact dermatitis, and allergy.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The antibacterial and antifungal activity of thimerosal has
been used as preservatives for various biological products,
including vaccines, cleaning solutions for eye lenses, as well
as cosmetics. The wide use of thimerosal in biological
materials has often resulted in public health issues by causing
thimerosal-mediated side effects such as contact dermatitis,
and inflammatory responses [1,2]. Thimerosal in cleaning
solutions for eye lenses has been previously shown to
produce cytotoxicity for corneal epithelial cells [3–5]. The
molecular mechanism of the side effects, however, has not
been clearly described yet. The most well-characterized
biological activity of thimerosal is the intracellular calcium
mobilization by thimerosal, which has been previously
manifested in many different cell types, such as smooth
muscle cells, endothelial cells, HeLa cells, platelets, neutro-
phils, lymphocytes, and so on [6]. Thimerosal is a thiosali-
cylic acid derivative containing ethyl mercury (Fig. 1A) and
the mercury atom is essential for the calcium mobilizing
activity of the compound. Thiosalicylic acid, a thimerosal
structural analogue, which does not contain the ethyl mer-
cury, has no calcium releasing activity. Furthermore, the
mercury atom of thimerosal gives the compound an oxida-
tive character and some protein sulfhydryl groups, such as
ATPase Ca2 + pump of the sarcoplasmic reticulum, are
reported to be redox modulated by thimerosal [7]. In this
study, we suggest that focal adhesion kinase (FAK) is one of
the important target molecules of thimerosal.
FAK is a nonreceptor protein tyrosine kinase (PTK) and a
key mediator of integrin signaling, which implicates its
regulatory roles in cell adhesion, spreading, migration as
well as cell survival and proliferation. Stimulation of FAK
tyrosine phosphorylation has been reported in many differ-
ent cell types by various kinds of stimuli, which can be
integrin-independent or integrin-dependent [8]. Upon stim-
ulation, FAK can be autophosphorylated on tyrosine 397,
recruiting other nonreceptor PTKs, pp60src and pp59fyn,
via their SH2 domains [9], which can create additional
tyrosine phosphorylation on other residues of FAK. As
one of the integrin-independent signals, H2O2 has been
reported to induce FAK tyrosine phosphorylation in vascu-
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lar endothelial cells [10]. Although there are plenty of
pathophysiological studies on thimerosal, the molecular
mechanism of its action has not been appropriately
described yet. In the present study, we report that thimerosal
can effectively phosphorylate the tyrosine residue of FAK
and also induce cytoskeletal changes by intracellular ROS
generation. This result will give us some clue for under-
standing the mechanism of thimerosal-mediated side effects
at the subcellular level.
2. Materials and methods
2.1. Reagents and antibodies
Thimerosal (mercury-[(o-carboxyphenyl) thio]-ethyl
sodium salt) and N-acetyl-L-cysteine (NAC) were purchased
from Sigma. Thiosalicylic acid was purchased from Aldrich
Chem. Co. BAPTA-AM, Rhodamine-phalloidin, 2,7-
dichlorofluorescin diacetate (DCFH-DA) and fluo-3, AM
were obtained from Molecular Probes, Inc. (Eugene, OR,
USA). PTK inhibitors, Tyrphostin (AG-82), Herbimycin A,
and Genistein were purchased from Calbiochem (La Jolla,
CA, USA).
Monoclonal anti-phosphotyrosine antibody (clone 4G10)
was purchased from Upstate Biotechnology (Lake Placid,
NY, USA). Rabbit polyclonal anti-FAK antibody was pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Rabbit polyclonal anti-FAK [pY397] antibody was
purchased from Biosource International (Camarillo, CA,
USA). Monoclonal anti-GAPDH antibody (clone 6G5)
was purchased from Biogenesis Ltd. (England, UK).
2.2. Cell culture
HeLa S cells were maintained in anchorage culture in
complete DMEM supplemented with 10% heat-inactivated
bovine calf serum. HeLa S cells can grow and proliferate
either in anchorage culture (triangular-shaped morphology)
or in suspension culture (round-shaped morphology)
depending on the kinds of culture dishware used, a regular
cell culture dish or a petri dish, respectively. Although the
growing morphologies of HeLa S cells are considerably
different depending on the culture dishes used, they grow
extremely well in both culture conditions. In all the experi-
ments, HeLa S cells were serum-starved for 36 h before the
treatment of thimerosal, unless otherwise indicated.
2.3. Thimerosal treatment and Western blotting
Serum-starved HeLa S cells were treated with or without
thimerosal for indicated times. Effects of various kinds of
inhibitors were examined by the preincubation of cells with
an inhibitor for 1 h before thimerosal treatment. The cells
were washed with PBS and treated with lysis buffer (1%
Triton X-100, 150 mM NaCl, 20 mM Tris–HCl, pH 7.4, 50
mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, 1 Ag/
ml leupeptin, 5 Ag/ml aprotinin and 2 AM pepstatin A) on
Fig. 1. Protein tyrosine phosphorylation by thimerosal. (A) Chemical structures of thimerosal and thiosalicylic acid show that ethyl mercury is the only
difference between the two molecules. (B) HeLa S cells were serum-starved (36 h) and treated with or without 50 AM thimerosal for 30 min. The cells were
rinsed with PBS and the cell lysates were prepared as described in Materials and methods. The samples transferred to nitrocellulose membrane were blotted
with monoclonal anti-phosphotyrosine antibody (clone 4G10). (C) Serum-starved (36 h) HeLa S cells were treated for 30 min with either thimerosal or
thiosalicylic acid at concentrations of 0, 1, 2, 5, 10, or 20 AM of each compound, respectively. Protein tyrosine phosphorylations were determined by blotting
with monoclonal anti-phosphotyrosine antibody (4G10). (D) Serum-starved (36 h) HeLa S cells were treated with 20 AM thimerosal for 0, 1, 2, 5, 10, 20, 50, or
100 min, respectively. The samples were prepared and blotted as described in (A). Protein tyrosine phosphorylations were determined by Western blotting with
monoclonal anti-phosphotyrosine antibody (4G10). The molecular weight size markers were shown on the left.
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ice. Lysates were scraped from the plates with a rubber
policeman and the supernatants were obtained after centri-
fugation at 15,000 rpm for 10 min at 4 jC. Protein
concentrations of the clarified cell lysates were determined
using Bradford assay. The cell lysates were added with
(5 ) SDS sample buffer and heated at 95 jC for 5 min. The
proteins were separated by 6–16% SDS-PAGE, then trans-
ferred to nitrocellulose membranes. Blocking was per-
formed with TTBS buffer (10 mM Tris–HCl (pH 7.6),
150 mM NaCl, 0.1% Tween 20) containing 5% skim milk
powder. The membranes were then incubated with primary
antibody for 4 h at room temperature. Immunoblots were
washed for 2 h with changing TTBS buffer for every 20
min, then incubated with horseradish peroxidase-linked
secondary antibody for 30 min at room temperature. Immu-
noblots were washed for 1 h with changing TTBS buffer for
every 10 min, and developed with horseradish peroxidase-
dependent chemiluminescence (ECL) (Amersham Corp.).
2.4. Immunoprecipitation
The cells were rinsed with PBS and the cell lysates were
prepared as described in the above Western blotting. The
protein concentrations of the cell lysates were determined
and the same amount of cell lysate protein was incubated
with rabbit polyclonal anti-FAK antibody-immobilized on
protein A resin for 2 h. After brief centrifugation, the
immunoprecipitates were washed three times with ice-cold
lysis buffer before being loaded onto a polyacrylamide gel
for Western blot analysis.
2.5. Detection of intracellular ROS generation
HeLa S cells grown on cover slips were serum-starved
for 36 h and loaded at room temperature with the ROS-
sensitive dye DCFH-DA, 20 AM for 15 min, followed by
washing out of the dye. A 30-min post-incubation period
was allotted for intracellular deacetylation of the dye, which
results in the formation of the nonfluorescent dichlorofluor-
escein (DCFH). After the post-incubation of DCFH-DA, the
cells were treated with thimerosal for indicated times. Upon
oxidation by ROS, dichlorofluorescin is converted to the
highly fluorescent dichlorofluorescein (DCF). After rinsing
four times with PBS, the slides were examined using
excitation wavelength of 490 nm and emission fluorescence
at 520 nm.
2.6. Detection of intracellular calcium release
Thimerosal-induced intracellular calcium release was
measured in HeLa S cells with fluo-3, AM, a calcium
specific fluorescent dye using a confocal microscopy (Zeiss,
Denmark). Briefly speaking, cells were loaded with fluo-3
(for 45 min) with or without intracellular calcium chelator
(BAPTA-AM 10 AM for 30 min), and washed with calcium-
free Locke’s solution (NaCl 158.4 mM, KCl 5.6 mM,
MgCl2 1.2 mM, HEPES, 5 mM at pH 7.3, glucose 10
mM, EGTA 0.2 mM) for three times. The cells were then
treated with thimerosal (30 AM) for inducing calcium
release. Thiosalicylic acid, a structural analog of thimerosal,
was tested to compare with thimerosal. The real time images
of intracellular calcium release in live cells were measured
for 14 min under confocal microscopy using excitation
wavelength of 477 nm and emission fluorescence at 500
nm. The 13-s-interval captured images were analyzed for
the determination of calcium release kinetics.
2.7. Fluorescence analysis of cytoskeletal changes
HeLa S cells grown on cover slips were serum-starved
for 36 h and treated with or without thimerosal for indicated
times in the presence or absence of various inhibitors. The
cells were rinsed with PBS for four times and fixed with 4%
(w/v) paraformaldehyde for 15 min at 37 jC. After rinsing
with PBS and blocking with PBS containing 1% horse
serum and 0.5% TX-100 for 1 h at 25 jC, the cells were
incubated with rhodamine-conjugated phalloidin dissolved
in PBS containing 1% horse serum and 0.5% TX-100 for 1
h at 25 jC. After rinsing four times with PBS containing
0.05% TX-100, the slides were examined under a fluores-
cence microscope (Zeiss).
3. Results and discussion
3.1. Thimerosal induces protein tyrosine phosphorylation
Thimerosal is a well-known intracellular calcium mobi-
lizer and reported to sensitize inositol 1,4,5-trisphosphate
(InsP3) receptors [11,12]. Hence, we have strongly suspected
that thimerosal may play some roles in calcium-associated
signaling pathways. As protein tyrosine phosphorylation is
one of the key events in cell signal transduction, we
investigated the protein profiles that are tyrosine phos-
phorylated by thimerosal in HeLa S cells using monoclonal
anti-phosphotyrosine antibody (clone 4G10). From the
study, we have observed several tyrosine-phosphorylated
proteins and 110–130 kDa proteins were most prominently
detected among others from thimerosal treatment (Fig. 1B).
Thimerosal is a membrane-permeable compound. As
shown in Fig. 1A, thimerosal has a mercury atom in the
molecule, and it is the only structural difference comparing
with its structural analogue, thiosalicylic acid, which did
not induce the protein tyrosine phosphorylation (Fig. 1C).
This implicates that the mercury in thimerosal is essential
for its stimulation of protein tyrosine phosphorylation.
Thimerosal-induced phosphorylation was increased in the
time- and the concentration-dependent manner (Fig. 1C,
D). The kinetic mode of thimerosal-induced tyrosine phos-
phorylation (Fig. 1D) suggests that it acts inside cells rather
than on plasma membrane receptor. As an ophthalmic
preservative, thimerosal has been clinically used at the
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concentration of 0.001–0.004%, which is equal to 25–100
AM in molarity. This concentration of thimerosal has been
previously reported to be toxic from in vitro cytotoxicity
study as well as in vivo and preclinical corneal epithelial
toxicity studies [13]. Therefore, we assumed the concen-
trations of thimerosal used in the present study were
appropriate and in relevant ranges.
3.2. Thimerosal induces generation of reactive oxygen
species (ROS) as well as calcium release
Thimerosal has a mercury atom in the molecule and
mercury atom has been reported to generate ROS in certain
cell types [14]. ROS generation by thimerosal, however, has
been poorly studied. We suspected that thimerosal may
induce ROS generation and examined the possibility in
thimerosal-treated HeLa S cells using ROS-sensitive fluo-
rescent dye DCFH-DA. The nonfluorescent probe DCFH-
DA readily crosses the cell membrane and undergoes
hydrolysis by intracellular esterases to nonfluorescent
DCFH [15,16]. DCFH is then oxidized in the presence of
ROS to highly fluorescent DCF. As we had expected, we
could observe that thimerosal significantly increased
DCFH-DA fluorescent staining in HeLa S cells, suggesting
that thimerosal induces ROS generation (Fig. 2A). DCFH-
DA is relatively more sensitive to H2O2, which suggests
H2O2 is generated by thimerosal treatment. The result,
however, does not rule out the possibility of generation of
other ROS molecules together with H2O2 by thimerosal.
This is a quite interesting result which may explain the
Fig. 2. Generation of ROS and calcium release by thimerosal. (A) HeLa S cells grown on cover slips were serum-starved for 36 h and loaded with the ROS-
sensitive dye 2,7-dichlorofluorescin diacetate (DCFH-DA, 20 AM) for 15 min. After the 30 min post-incubation period, the cells were treated for 30 min with
either vehicle alone (A), 10 AM thiosalicylic acid (B), 10 AM thimerosal (C), or 1 mM H2O2 (D), respectively. The intracellular ROS generations of the treated
cells were examined using the DCFH-DA fluorescence signals at excitation wavelength of 490 nm and emission fluorescence at 520 nm by fluorescence
microscopy. Arrows indicate the cells showing ROS-sensitive DCFH-DA fluorescence. (B) Under the similar condition of (A), thimerosal-induced intracellular
calcium releases were measured in HeLa S cells with a confocal microscopy (Zeiss) using fluo-3, AM, a calcium specific fluorescent dye. Cells were loaded
with fluo-3 (for 45 min) with or without intracellular calcium chelator (BAPTA-AM 10 AM for 30 min), then washed and treated with indicated concentrations
of thimerosal for inducing calcium release. The real time intracellular calcium release in live cells was measured for 14 min. The calcium release kinetics shown
was the representatives of three cells of each experiment. Arrow indicates the treatment of thimerosal (TM). AU (arbitrary unit).
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reason why thimerosal can cause contact dermatitis, a
known side effect of thimerosal [1,2]. ROS have been
reported as a cause of contact dermatitis [17] and we clearly
showed that thimerosal could generate ROS in HeLa S cells
(an epithelial cell line). Therefore, it is very likely that
thimerosal-generated ROS can lead to contact dermatitis as
a mechanism of the side effect. ROS have also been
implicated in a diverse array of biological processes, such
as antimicrobial defense, radiation damage, photobiological
effects, and aging. Furthermore, it is now apparent that
ROS, as second messengers, can play important roles in
inter- and intracellular signaling [18,19]. With these find-
ings, we proposed that ROS generation and protein tyrosine
phosphorylation could play a central role in thimerosal-
mediated signal transduction.
Thimerosal has been well known to stimulate intracel-
lular calcium mobilization that has been previously reported
in various cell types. We have tested whether thimerosal can
induce intracellular calcium release in HeLa S cells. As in
other cell types, thimerosal was able to stimulate intra-
cellular calcium release in HeLa S cells, which can be
blocked by BAPTA-AM pretreatment (Fig. 2B). It is not
clear if reactive oxygen or calcium plays an important role
in protein tyrosine phosphorylation in HeLa S cells. This
issue was further investigated in the following study.
3.3. Focal adhesion kinase (FAK) is tyrosine
phosphorylated by thimerosal
To identify the tyrosine-phosphorylated 110–130 kDa
proteins, the immunoprecipitates of anti-phosphotyrosine
antibody (clone 4G10) of cell lysate were immunoblotted
with various antibodies. From the experiments, FAK was
identified to be tyrosine phosphorylated by thimerosal (Fig.
3A). We could also observe the tyrosine phosphorylation of
other focal adhesion proteins by thimerosal, such as paxillin,
p130Cas, and Pyk2 as well (data not shown). For the present
study, we focused on FAK as a major player in focal
Fig. 3. Thimerosal induces FAK tyrosine phosphorylation and actin cytoskeletal changes. (A) HeLa S cells were serum-starved (36 h) and treated for 30 min
with thimerosal at concentrations of 0, 0.2, 0.5, 1, 2, 5, 10, 20 AM, respectively. The cells were rinsed with PBS and the cell lysates were prepared as described
in Materials and methods. For immunoprecipitation, the cell lysates were incubated with rabbit polyclonal anti-FAK antibody-immobilized on protein A resin
for 2 h. After brief centrifugation, the immunoprecipitates were washed three times with ice-cold lysis buffer before being loaded onto a polyacrylamide gel.
Western blotting was performed with monoclonal anti-phosphotyrosine antibody (4G10). (B) Serum-starved (36 h) HeLa S cells were preincubated for 20 min
with or without sodium vanadate (0.1 mM), an inhibitor of protein tyrosine phosphatases. The cells were then treated for 30 min with thimerosal at
concentrations of 0, 1, 2, 5, 10, or 20 AM, respectively. Rabbit polyclonal anti-FAK [pY397] antibody was used for the blotting of FAK. The protein amount of
each lane was shown together in the figure by Western blotting with mouse monoclonal anti-GAPDH antibody. The molecular weight size markers were shown
on the left. (C) HeLa S cells grown on cover slips were serum-starved for 36 h, then treated with vehicle alone (A) or 10 AM thimerosal for 10 min (B), and 60
min (C), respectively. After rinsing, the cells were fixed and their filamentous actin (F-actin) were visualized by staining with rhodamine-conjugated phalloidin
under a fluorescence microscope (Zeiss). Arrowheads and arrows indicate the plasma membrane protrusions and actin stress fibers, respectively.
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adhesions. Protein tyrosine phosphorylation is one of the
most important protein modifications in cell signaling and
tightly regulated by the opposing actions of protein tyrosine
kinase (PTK) and protein tyrosine phosphatases (PTP).
Specially, it is a central event in ligand-specific cell surface
receptor signal transduction, which is related to mitogenesis,
cell differentiation, cell adhesion, oncogenic cell transfor-
mation and apoptosis [20–22]. Many reports have sug-
gested that redox active molecules including ROS, sulf-
hydryl oxidants, redox metals and nitric oxide (NO) are
modulators of PTK and PTP activities [23,24]. Since PTP
can be inhibited by ROS [25], thimerosal-induced FAK
tyrosine phosphorylation can be the result of inhibition of
PTPs by thimerosal-generated ROS. For testing this, thi-
merosal-induced FAK tyrosine phosphorylations were deter-
mined in the presence of vanadate, an inhibitor of PTPs,
using rabbit polyclonal anti-FAK [pY397] antibody (Fig.
3B). Although the pretreatment of vanadate slightly
enhanced the basal tyrosine phosphorylation of FAK, thi-
merosal was still able to further enhance FAK tyrosine
phosphorylation at its highest concentration in the presence
of vanadate. This result proposes that thimerosal-induced
FAK tyrosine phosphorylation may be mediated partially by
PTP inhibition of thimerosal-generated ROS but also by
some other mechanisms, such as direct redox regulation of
FAK by thimerosal. In fact, there are evidences of chemi-
cally induced redox modulation of proteins [26]. The
molecular mechanism of FAK stimulation by ROS is not
clear from the present result and will be studied in the
future.
3.4. Thimerosal triggers cell morphological changes and
actin stress fiber formation
It has been previously shown that PTK can mediate actin
polymerization and the morphological changes are accom-
panied by changes in p-tyr content of the focal adhesion
Fig. 4. Tyrphostin and NAC inhibits thimerosal-induced FAK tyrosine
phosphorylation. (A) Effects of various PTK inhibitors on thimerosal-
induced FAK tyrosine phosphorylation were examined using serum-
starved (36 h) HeLa S cells. The cells were preincubated for 1 h in the
absence or presence of PTK inhibitors, including genistein (100 AM),
herbimycin A (5 AM), tyrphostin (100 AM), respectively and then treated
with or without 20 AM thimerosal for another 30 min. The FAK tyrosine
phosphorylation was examined by Western blotting with rabbit polyclonal
anti-FAK [pY397] antibody. (B) The serum-starved HeLa S cells were
preincubated for 1 h with vehicle alone, BAPTA (10 AM) or NAC (20 mM),
and then treated for additional 30 min with or without 20 AM thimerosal. The
FAK tyrosine phosphorylation was examined as described above. The
molecular weight size markers were shown on the right.
Fig. 5. Inhibition of thimerosal-induced actin cytoskeletal changes by tyrphostin and NAC. HeLa S cells grown on cover slips were serum-starved for 36 h
then pretreated with vehicle alone (A, B), 100 AM tyrphostin (C, D) or 20 mM NAC (E, F) for 1 h. The cells were then treated for additional 30 min without
(A, C, E) or with (B, D, F) 20 AM of thimerosal. The filamentous actin (F-actin) were visualized by staining with rhodamine-conjugated phalloidin and
examined by fluorescence microscopy.
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contact-associated protein FAK [10,27,28]. Since thimerosal
induced the tyrosine phosphorylation of FAK, we were
inspired to examine actin cytoskeletal organization in thi-
merosal-treated cells. From the study, we could observe
some dramatic cytoskeletal changes, including the forma-
tion of plasma membrane protrusions and the increase of
actin stress fibers (Fig. 3C). When the cells were double-
stained using monoclonal anti-FAK antibody and rhod-
amine-conjugated phalloidin, FAK was observed to highly
localize at the area of membrane protrusions (data not
shown). The present results are consistent with other pre-
vious reports that PTK has important roles in mediating
focal adhesion site remodeling [29]. Interestingly, the HeLa
S cells treated with H2O2 did not induce the formation of
membrane protrusions as has been shown in the thimerosal
treatment (Fig. 3C). Thus, H2O2 seems to induce FAK
tyrosine phosphorylation as well as actin stress fiber for-
mation, as previously reported by other investigators [10],
whereas membrane protrusions by thimerosal are mediated
by different mechanisms other than H2O2. These results
suggest that thimerosal has an additional and more complex
mode of action as well as a stronger impact on cytoskeletal
changes than H2O2 alone.
3.5. Tyrphostin as well as N-acetyl-L-cysteine block
thimerosal-induced protein tyrosine phosphorylation and
cytoskeletal change
Protein tyrosine phosphorylation in thimerosal-treated
cells was examined with or without PTK inhibitors, such
as genistein, herbimycin A, or tyrphostin, respectively
(Fig. 4A). Neither genistein, a general PTK inhibitor nor
herbimycin A, another tyrosine kinase inhibitor, was able
to block the thimerosal-induced protein tyrosine phosphor-
ylation. On the other hand, tyrphostin, a FAK tyrosine
kinase inhibitor almost completely inhibited the tyrosine
phosphorylation. The result confirms that FAK is tyrosine
phosphorylated by thimerosal. It has now become apparent
that thimerosal is a ROS generator as well as an intra-
cellular calcium mobilizer, and we have determined the
roles of ROS and calcium in thimerosal-induced tyrosine
phosphorylation. BAPTA, a membrane permeable intra-
cellular calcium chelator, did not affect thimerosal-induced
protein tyrosine phosphorylation, whereas NAC, a ROS
scavenger, significantly inhibited the tyrosine phosphory-
lation (Fig. 4B). Therefore, we propose that the FAK
tyrosine phosphorylation is likely related not to the cal-
cium mobilizing activity but to the redox activity of
thimerosal, which can be blocked by either FAK inhibitor
or ROS scavenger. When the cytoskeletal changes induced
by thimerosal were examined with or without tyrphostin
and NAC, respectively, both anti-effectors showed a sig-
nificant inhibition of actin stress fiber formation as well as
plasma membrane protrusions stimulated by thimerosal
(Fig. 5). This result was well correlated with that of
FAK tyrosine phosphorylation (Fig. 4).
In summary, we have shown that thimerosal can generate
ROS, thereby induce FAK tyrosine phosphorylation and
actin cytoskeletal changes. The present study will be a help
to understand thimerosal-mediated side effects, such as
contact dermatitis, allergy and other inflammatory diseases.
Further studies will be required to determine the molecular
mechanism of redox-sensitive FAK activation.
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